Detect biomarkers associated with nonalcoholic fatty liver disease (NAFLD)
Detect biomarkers associated with nonalcoholic fatty liver disease (NAFLD)
Abstract
In this 1-hour discussion, learn how the SomaScan® Assay can be used to detect biomarkers associated with NAFLD—specifically, the identification of circulating proteins associated with fibrosis in NAFLD using a custom 5k-plex SomaScan Assay. Also discussed is the importance of identifying non-invasive biomarkers that improve clinical decision-making and drug development for NAFLD, and the strategies for multiplexed validation of candidate biomarkers discovered using the SomaScan Assay.

Kathleen Corey, MD, MPH, MMSc
Director of the Massachusetts General Hospital NAFLD program and an Assistant Professor of Medicine at Harvard Medical School

Rebecca Pitts
Principal scientist at the Novartis Institutes for BioMedical Research in Cambridge, Massachusetts
Detect biomarkers associated with nonalcoholic fatty liver disease (NAFLD)
A webinar presented by Kathleen Corey, MD, MPH, MMSc, and Rebecca Pitts
More webinars
WebinarDesigning for discovery: Study design and statistical power in high‑dimensional proteomics
In high‑dimensional proteomics, “more proteins” doesn’t automatically mean “more discovery.” The reliability of your findings still depends on study design choices that determine statistical power, reproducibility, and signal‑to‑noise—long before the first model is run.
WebinarOpening the black box: Building and evaluating machine learning models for proteomics
Machine learning can be a powerful way to extract multivariate signals from high-dimensional proteomics data, but only when models are built and evaluated with rigor. In this on-demand webinar, explore a practical framework for developing predictive and explanatory models, with an emphasis on study design choices that help prevent data leakage, reduce overfitting, and improve reproducibility.
WebinarBeyond the trees: See the bigger biological picture with pathway enrichment analysis
Proteomic data holds enormous potential—but the biology is rarely contained in a single protein. When you’re handed a list of differentially abundant proteins, the next challenge is turning that list into a clear, testable story about mechanisms and processes.
